To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Heinrich Emanuel Merck Award 2012 granted to Professor Aaron Wheeler
13-08-2012: Merck announced that the 2012 Heinrich Emanuel Merck Award for Analytical Science will be given to Professor Wheeler from the University of Toronto for his development of a digital microfluidic method for the extraction and quantification of estrogen in 1-microliter samples of breast tissue homogenate, whole blood and serum. This method may be broadly applicable for diagnostics requiring frequent analysis of hormones in clinical samples, which are important markers for example in infertility or cancer. The award, endowed with € 15,000, will be presented to Professor Wheeler at Merck Millipore’s Technology Exposition in Bedford, Massachusetts, USA, on October 17, 2012.
“Professor Wheeler`s development of new analytical methods using digital microfluidic technology to overcome the limitations of conventional techniques in the extraction and quantification of estrogen is an outstanding scientific achievement with significant societal impact, for example in breast cancer diagnosis,” explained Professor Reinhard Niessner (Technical University of Munich, Germany), the head of the international jury for the Heinrich Emanuel Merck Award.
“By selecting Aaron Wheeler, we are recognizing a talented and very successful scientist. We are looking forward to his award lecture in October,” said Dr. Thomas Geelhaar, Chief Technology Officer Chemicals at Merck. “Thanks to his groundbreaking scientific approach, Professor Wheeler has helped to achieve tremendous advances in the research field of hormone analysis.”
Aaron R. Wheeler (37) is an Associate Professor at the University of Toronto, Department of Chemistry. The Wheeler research group is developing hybrid methods that rely on the unique advantages of microchannels and digital microfluidics for applications in the areas of chemistry, biology, and medicine.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
- 1Pro Bono Bio Launches Flexiseq: A Novel Approach to the Treatment of Osteoarthritis
- 2Rosetta Resolver® Gene Expression Data Analysis System licensed by Aventis Pharmaceuticals, Inc.
- 3Vivacta Initiates Development of Point of Care Test for Vitamin D
- 4Using human brain cells to make mice smarter
- 5Pharma’s New Hero: Supergenerics Save Money and Improve Drugs
- 6Fighting listeria and other food-borne illnesses with nanobiotechnology
- 7A light switch inside the brain
- 8Researchers divide enzyme to conquer genetic puzzle
- 9New study confirms fungal infection of the foot is a risk factor for bacterial tissue infection of the leg
- 10Pharmexa enters into an agreement regarding GV1001 with the Korean company KAEL Co. Ltd
- Unique method creates correct mirror image of molecule
- KI becomes first university in Sweden to offer open online courses for a glo ...
- Successful results in developing oral vaccin against diarrhea
- Stratified Medicine Scotland Innovation Centre appoints chairman
- Innovative medication to shatter blood clots with light
- EMBO announces new members for 2013
- Evotec and Harvard University to collaborate on development of new class of antibacterials
- Carl Zeiss Meditec improves its results in first six months of financial year 2012/2013
- Evonik selects OPX Biotechnologies for joint development of bio-based chemicals
- Frost & Sullivan commends Merck Serono for its excellence in product differentiation
